Generate a tailored SOP for Dr. Geoffrey Hill. Improve your application with a focused, well-structured draft.
Dr. Geoffrey Hill is a physician-scientist specializing in blood stem cell transplantation, particularly focusing on the immunological mechanisms initiating acute and chronic forms of graft-vs.-host disease (GVHD). His research aims to minimize GVHD and make transplantation more tolerable for patients, while also working to reduce infection, relapse, and immunological rejection of transplanted cells. Dr. Hill's lab has demonstrated that cell-signaling molecules called cytokines play critical roles in transplant outcomes, and his team's findings have led to new therapies for GVHD, helping establish new standards of care for transplant patients. He also collaborates with colleagues at Fred Hutch to develop methods integrating transplantation with cancer immunotherapy, such as T-cell therapy. With over 195 scientific publications, his studies have tackled major limitations of bone marrow transplantation, including GVHD, opportunistic infections, and graft rejection. Dr. Hill's ongoing research includes enhancing anti-tumor efficacy through cytokines and studying the interactions between different cell types in HCT outcomes.
Fred Hutch Cancer Center • Seattle, WA
Director, Translational Science Therapeutics Division.
University of Washington • Seattle, WA
Division of Hematology Oncology.
Standard Graduate School requirements for University of Washington apply to most departments listed unless specified otherwise by the program.